Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-29 @ 12:56 PM
Study NCT ID:
NCT07194850
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2025-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-19
First Submit QC Date:
None
Study First Post Date:
2025-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED